Educational information only – not medical advice. Costs and coverage vary by plan; confirm your own benefits with your insurer and the clinic before treatment.

For people whose depression has not responded to standard medication, Spravato (esketamine) is one of the newer options, and the question that comes up most is not how the medicine works. It is simpler: what is this going to cost me? The honest answer surprises people, because with Spravato you are never paying for just a drug. Here is how the money actually works.

You are paying for two things, not one

Spravato is a nasal spray, but it is not a prescription you pick up at a pharmacy and take home. Federal safety rules (the REMS program, explained below) require it to be given at a certified clinic, with clinicians watching you for at least two hours afterward. So every treatment has two charges: the medication itself, and the clinic’s time – the staff, the room, and the monitoring. When a price quote looks confusing, it is usually because one of those two parts was left out.

What it costs without insurance

Without coverage, the medication alone runs roughly $600 to $900 per treatment session, depending on your dose (56 mg or 84 mg). The clinic’s administration and observation fee typically adds $150 to $400. All in, most self-pay quotes land between $700 and $1,200 per session.

The first month is the expensive part. Treatment is twice a week for the first four weeks – eight sessions – which can add up to roughly $4,000 to $9,500 before the schedule thins out to weekly, then every week or two. Very few patients end up paying the full cash price, because insurance covers Spravato more often than people expect, if you meet the criteria and the paperwork is done right.

What it costs with insurance

Most health plans cover Spravato for treatment-resistant depression, usually under the medical benefit rather than the pharmacy benefit. With an approved authorization, patients commonly report copays in the $10 to $60 range per session, though a deductible can change that picture early in the year. Medicare covers it when the criteria are met, but the math is different: Spravato is paid under Part B, the medical benefit, because it is given and monitored in the clinic. After you meet the annual Part B deductible ($283 in 2026), you owe 20 percent of the Medicare-approved amount for each session – the drug and the observation billed together – and Original Medicare puts no yearly cap on that 20 percent, though a Medigap supplement policy can cover it, and Medicare Advantage plans set their own copays instead. (Sources: CMS, 2026 Medicare Parts A and B Premiums and Deductibles, https://www.cms.gov/newsroom/fact-sheets/2026-medicare-parts-b-premiums-deductibles ; Novamind, Medicare Part B vs Part D for Spravato, https://novamindmentalhealth.com/resources/medicare-part-b-vs-part-d-spravato/) The manufacturer’s savings program, SPRAVATO withMe (the current name for what many clinics still call Janssen CarePath), is for commercially insured patients only: if you have private insurance, are 18 or older, and are enrolled in the REMS program, it can cut what you pay for the medicine itself to as little as $10 per treatment, with savings capped at $8,150 per calendar year. It does not pay the clinic’s observation fee – a separate withMe Observation Rebate Program covers that piece, rebating your out-of-pocket observation costs up to $500 per calendar year (not offered in MA, MI, MN, or RI). Government insurance, including Medicare and Medicaid, cannot use either program, and no income information is required. (Sources: Johnson & Johnson, SPRAVATO withMe Savings Program overview, https://asset.jnjwithme.com/document/spravato-withme-savings-program-overview.pdf?v=20251107 ; Johnson & Johnson, SPRAVATO withMe Observation Rebate Program overview, https://asset.jnjwithme.com/document/spravato-withme-observation-rebate-program-overview.pdf?v=20250814 ; HealingMaps, Spravato Cost 2026, https://healingmaps.com/spravato-cost-insurance-coverage/) Ask the clinic about both before your first session, not after.

How the medicine reaches the clinic matters too, and it explains a phone call that confuses many patients. Depending on your insurance, the clinic gets Spravato one of two ways. With “buy-and-bill,” the clinic buys the medication itself, gives it to you, and bills your medical insurance for the whole package – drug and visit together. With the “specialty pharmacy” route, a third-party pharmacy runs the drug through your pharmacy benefit, ships the spray directly to the clinic with your name on it, and bills you separately for the drug copay – which is why the pharmacy calls you about a copay for a medicine you only ever take at the clinic. The clinic still bills its own observation fee on top of that. Knowing which route your plan requires tells you who to call when a bill looks wrong.

If you want to check your exact benefits yourself, call your insurer and ask them to run the codes – their representatives usually need them. For the medication itself, clinics most often bill the Spravato-specific code S0013 (esketamine, per 1 mg); some plans use the unclassified-drug code J3490 instead. For the visit and the two hours of observation, clinics bill evaluation and management codes, and Medicare uses bundled codes – G2082 for the 56 mg dose and G2083 for the 84 mg dose – that combine the drug and the observation in one charge. Codes and rules change, and every plan differs, so treat this as the starting list for the conversation, not a guarantee of what you will owe.

Prior authorization: the part nobody warns you about

Before your first treatment, the clinic has to get your insurer’s permission. This is called prior authorization, and it is where Spravato treatment is often won or lost. Insurers generally want documented proof that standard treatment has not worked: typically at least two antidepressants, from different drug classes, each taken at a proper dose for at least six weeks during the current episode of depression. They also want your diagnosis documented and symptom scores (usually a PHQ-9 questionnaire) on file.

Two practical things are worth knowing. First, timelines: a decision often takes one to two weeks, and it moves faster when the documentation is complete the first time. Second, most denials are paperwork problems, not medical ones. The most common reason is a medication history missing the exact dates or doses of a past antidepressant trial. A good clinic runs a benefits investigation before you are scheduled, confirms whether your plan pays under the medical or pharmacy benefit, and appeals with better documentation if the first answer is no. Ask them if they do all that. If they shrug, find another clinic.

One more wrinkle. The FDA approved Spravato as a stand-alone treatment in January 2025, without a daily antidepressant pill alongside it, but many insurers have been slow to update their coverage rules to match. Your plan may still require you to be taking an oral antidepressant before it will approve the claim. A sharp clinic billing team will know your specific insurer’s current rules – it is worth asking before the paperwork starts.

The REMS rules are not optional

Spravato is available only through certified treatment centers under a federal safety program called REMS. You enroll in the program. The spray is given at the clinic – you administer it yourself, under staff supervision. Then you stay for observation for at least two hours while staff check your blood pressure and watch for sedation and dissociation, a spaced-out, detached feeling that usually fades during the visit. A prescriber is on site the whole time. You cannot drive afterward, not until you have had a restful night’s sleep, so you need a ride home from every session. Any clinic offering to bend these rules is a clinic to walk away from.

Questions to ask a clinic before you start

• Are you a REMS-certified center, and is a prescriber on site during treatment?
• Have you verified my benefits, and is Spravato covered under my medical or pharmacy benefit?
• What will I actually pay per session, in writing, including the observation fee?
• If my plan requires the medication to come through a specialty pharmacy, will I owe a copay to the pharmacy and a separate observation copay to the clinic?
• What does your prior authorization process look like, and what happens if I am denied?
• How do you schedule the first month, and what happens if I miss a session?
• Who do I call that evening if I feel unwell after a treatment?

Spravato is a real commitment: of time, of logistics, and of money. The clinics that do it well will tell you all three numbers up front.

This page is educational information, not medical advice. Talk to your own clinician about whether Spravato is right for you.